No Data
No Data
US Stock Futures Rise as Investors Await Key Inflation Data
Express News | GlycoMimetics : On Feb 19, Received Notice From Apollomics (Hong Kong) Limited Terminating Collaboration and License Agreement
Apollomics Shares Are Trading Lower After the Company Announced Its Phase 3 Bridging Trial of Uproleselan in China Did Not Demonstrate a Favorable Benefit.
Apollomics Shares Down in Premarket After Leukemia Drug Misses Phase-3 Targets
Express News | Apollomics Inc - Serious Adverse Events 43% in Uproleselan Arm Vs 39% in Control
Express News | Apollomics Inc: Trial Did Not Demonstrate Favorable Benefit for Uproleselan
Trader evil : Hi, can i know where do you get this information from?
HailTheApocalypse Trader evil : Google
Trader evil HailTheApocalypse : Any specific way to get it? Or website
HailTheApocalypse Trader evil : look up low floats on Google